NANCY MYERS: Open Payments
NPI 1346470572 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 25 payments from 11 companies in 2025. Trend: 2023 $423 · 2024 $0 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $100 |
| CSL Behring | 3 | $78 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Lilly USA, LLC | 1 | $32 |
| GENZYME CORPORATION | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Grifols USA, LLC | 1 | $24 |
Products named: DUPIXENT, Hizentra, NEFFY, TRELEGY ELLIPTA, TEZSPIRE, AIRSUPRA, FASENRA, EBGLYSS.
Industry payments across VA — which companies pay providers there.
